Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.

Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...